Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. (APVO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · APVO · as of Sep 30, 2025
Ownership Breakdown
12
Institutional Holders
▲ 5 vs Q2
$717,121
Total Inst. Value
▲ $671,265 vs Q2
1.25M
Shares Outstanding
freeFloat 99.94%
493,997
13F Shares Held
▲ 478,962 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
APVO largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 299.9K | 1.57% | 1.57% | $434.92M | Nov 14, 2025 | NEW |
DRW SECURITIES, LLC pharmaceutical preparations | 131.5K | 68.87% | 68.87% | $190.65M | Nov 14, 2025 | NEW |
VIRTU FINANCIAL LLC pharmaceutical preparations | 38.3K | 20.05% | 20.05% | $56.00M | Nov 14, 2025 | NEW |
COLONY GROUP, LLC pharmaceutical preparations | 10.0K | 5.24% | 5.24% | $14.50M | Nov 14, 2025 | NEW |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 6.5K | 3.40% | 3.40% | $9.76M | Nov 14, 2025 | ▲ 3.3K |
UBS GROUP AG pharmaceutical preparations | 5.7K | 2.97% | 2.97% | $8.23M | Nov 13, 2025 | NEW |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 1.4K | 0.76% | 0.76% | $2.10M | Nov 14, 2025 | ▲ 253 |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 570 | 0.30% | 0.30% | $827,000 | Nov 5, 2025 | ▼ 18 |
CITIGROUP INC pharmaceutical preparations | 74 | 0.04% | 0.04% | $107,000 | Nov 10, 2025 | NEW |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 27 | 0.01% | 0.01% | $39,000 | Feb 3, 2026 | ▲ 24 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
3
Increased
+3.5K shares6
New Positions
first time holders1
Decreased
−18 shares2
Sold Out
fully exitedNet shares change (top 50)
+3.5K
+3.5K / −18
Net new holders
+6
6 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
APVO insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Grant Grady III director | Nov 10, 2025 | Purchase | 13,513 | $1.49 | $20.1K | 13.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Aptevo Therapeutics Inc. (APVO) is primarily owned by institutional investors, who hold approximately 39.6% of total shares outstanding. Company insiders own approximately 0.06%, while retail and public investors account for the remaining 60.29%.
The largest institutional shareholder of Aptevo Therapeutics Inc. is POINT72 ASSET MANAGEMENT, L.P., holding approximately 299,944 shares — equal to 1.57% of outstanding shares — as of September 30, 2025.
A total of 12 institutional investors currently hold APVO stock, with a combined institutional value of approximately $717,121 as of the most recent 13F filing period.
Frequently asked questions
APVO ownershipAptevo Therapeutics Inc. (APVO) is primarily owned by institutional investors, who hold approximately 39.6% of shares. The largest shareholder is POINT72 ASSET MANAGEMENT, L.P. with a 1.57% stake. Company insiders hold 0.06%. Data sourced from SEC Form 13F as of September 30, 2025.